Specialised Therapeutics
The company set a historic milestone in the treatment of multiple sclerosis when it launched the very first drug approved to treat this nervous disorder.
You can find more detailed information about our pharmaceutical brands, by visiting the Electronic Medicines Compendium (UK). This compendium supplies Patient Information Leaflets (PILs) and Summaries of Product Characteristics (SPCs).
